Global Hepatitis C Testing Market Report to 2031 – Players Include Abbott Laboratories, BIO-RAD Laboratories, Cosara Diagnostics and Illumina – ResearchAndMarkets.com

Posted on by

Global Hepatitis C Testing Market Report to 2031 – Players Include Abbott Laboratories, BIO-RAD Laboratories, Cosara Diagnostics and Illumina – ResearchAndMarkets.com




Global Hepatitis C Testing Market Report to 2031 – Players Include Abbott Laboratories, BIO-RAD Laboratories, Cosara Diagnostics and Illumina – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hepatitis C Testing Market By Technique, By Test, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.

The global hepatitis C testing market was valued at $1,329.0 million in 2021, and is projected to reach $2,248.2 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.

Hepatitis C is a viral infection that causes liver inflammation, sometimes leading to serious liver damage. The hepatitis C virus (HCV) spreads through contaminated blood. The hepatitis C can be diagnosed with antibody test, genotype test, and viral load test.

The increasing rate of hepatitis C and rise in awareness about hepatitis C drives the growth of market. For instance, according to a report of World Health Organization (WHO) published on June 2022, globally, an estimated 58 million people have chronic hepatitis C virus infection, with about 1.5 million new infections occurring per year. An estimated 3.2 million adolescents and children have the chronic hepatitis C infection. Thus, increase in prevalence of hepatitis C globally boosts the growth of the market.

In addition, factors such as increase in blood donation and rise in blood transfusion rate foster the growth of the market. The blood transfusion is a leading cause of hepatitis C virus transmission.

For instance, as per the report of World Health Organization (WHO) published on May 2022, about 118.54 million blood donations are made worldwide. 40% of these are collected in high-income countries. The World Health Organization (WHO) recommends that all blood donations should be screened for infections prior to use. Screening for HIV, hepatitis B, hepatitis C, and syphilis should be mandatory.

Moreover, increase in R&D activities for development of advanced hepatitis C testing such as immunoassay & polymerase chain reaction (PCR), rise in the U.S. food & drug administration (FDA) approvals and novel product launch in the market by key players boost the market growth.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hepatitis c testing market analysis from 2021 to 2031 to identify the prevailing hepatitis c testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the hepatitis c testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hepatitis c testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technique

  • Immunoassay
  • PCR
  • Type
  • Real time PCR
  • Other PCR
  • Other techniques

By Test

  • Antibody test
  • Genotype tests
  • Viral load test

By End User

  • Hospital and diagnostic laboratory
  • Blood banks
  • Other end users

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Europe
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest Of LAMEA

Key Market Players

  • Abbott Laboratories
  • BIO-RAD laboratories Inc
  • Cosara Diagnostics Pvt Ltd
  • Illumina Inc
  • Meril Life Sciences Pvt. Ltd.
  • Molbio Diagnostics Pvt. Ltd.
  • PerkinElmer
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc
  • Trivitron Healthcare

For more information about this report visit https://www.researchandmarkets.com/r/6zojz6

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900